首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
FORDONSMOTORANLEGGNING
摘要
申请公布号
SE8006805(L)
申请公布日期
1982.03.30
申请号
SE19800006805
申请日期
1980.09.29
申请人
UNITED MOTOR & TRANSMISSIONS A
发明人
KRONOGARD S-O;KRONOGARD C-O;KRONOGARD N H
分类号
B60K6/00;F02B1/04;F02B3/06;F02B39/04;F02B73/00;F02B75/12;F02D25/04;(IPC1-7):F02D17/00;E02D25/00;F02D25/00
主分类号
B60K6/00
代理机构
代理人
主权项
地址
您可能感兴趣的专利
METHOD AND DEVICE FOR EXTRACTING SIGNAL AND MEDIUM RECORDING SIGNAL EXTRACTION PROGRAM
Controllable underwater strobe light system for directing movement of fish
Werkwijze en inrichting voor de vervaardiging van producten door gebruikmaking van afvalmaterialen van verschillende soort, alsmede product verkregen met de werkwijze.
Indigestible oligosaccharides to treat diarrhea typically contained in infants milk beverages
Diamond of gemstone marking.
Controlling the particle size and particle size distribution in a process for continuous synthesis of molecular sieves.
Sulphonated amino acid derivatives and matrix metalloproteinase inhibitors (MMP) containing these derivatives
A topical pharmaceutical composition containing a sulphoquinovosy or sulphodeoxyhexosyl-diacyl glycerol
Preparation of hydrophillic macromolecules in hydrophobic solvents such as medium chain monoglycerides and diglcerides
Topical formulation of [R-(Z)-alpha-(methoxyimino)-alpha(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile for the treatment and/or prophylaxis of dementia
Tanning emulsion comprising at least one water-soluble dye with a colour which disappears when the emulsion dries
The use of compounds that are able to bind to the non-coding regions of a gene in the manufacture of a medicament for suppressing the expression of an endogenous gene
Humanized green fluorescent protein genes (GFP) and methods
Industrial antimicrobial/mildew-proofing agents, algicides and antifouling agents containing N-quinoxalylanilines
Method of making an article from an acrylic material with a backing material
Sulfonamide-substituted compounds affecting potassium channel opened by cAMP
4,9-Dihydro-4,9-dioxo-2-substituted-1H-naphtho[2,3]imidazole derivatives and their use in treating circulatory disorders
Aqueous formulations of peptides, preferably LHRH
use of substituted 3-benzyl-4-hydroxy-2H-1-benzopyran derivatives to prevent allograft rejection
An equipment cabinet and a method for controlling the temperature and relative humidity of the internal air inside
